Pomanda estimates the enterprise value of RENISHAW NEURO SOLUTIONS LTD at £3m based on a Turnover of £2.2m and 1.37x industry multiple (adjusted for size and gross margin).
renishaw neuro solutions ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of RENISHAW NEURO SOLUTIONS LTD at £0 based on an EBITDA of £-5.7m and a 8.13x industry multiple (adjusted for size and gross margin).
renishaw neuro solutions ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of RENISHAW NEURO SOLUTIONS LTD at £0 based on Net Assets of £-10.7m and 2.42x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Renishaw Neuro Solutions LtdOverview
Renishaw Neuro Solutions Ltd is a live company located in gloucestershire, GL12 8SP with a Companies House number of 10375761. It operates in the manufacture of irradiation, electromedical and electrotherapeutic equipment sector, SIC Code 26600. Founded in September 2016, it's largest shareholder is
renishaw medical limited
with a 100% stake. Renishaw Neuro Solutions Ltd is a young,
small sized company, Pomanda has estimated its turnover at
£2.2m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Renishaw Neuro Solutions Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
3 Strong
2 Regular
7 Weak
Size
annual sales of £2.2m, make it smaller than the average company (£20.3m)
£2.2m - Renishaw Neuro Solutions Ltd
£20.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 132%, show it is growing at a faster rate (-1.5%)
132% - Renishaw Neuro Solutions Ltd
-1.5% - Industry AVG
Production
with a gross margin of 56.5%, this company has a lower cost of product (30.5%)
56.5% - Renishaw Neuro Solutions Ltd
30.5% - Industry AVG
Profitability
an operating margin of -284.4% make it less profitable than the average company (0.5%)
-284.4% - Renishaw Neuro Solutions Ltd
0.5% - Industry AVG
Employees
with 47 employees, this is below the industry average (82)
47 - Renishaw Neuro Solutions Ltd
82 - Industry AVG
Pay Structure
on an average salary of £66.2k, the company has an equivalent pay structure (£58.5k)
£66.2k - Renishaw Neuro Solutions Ltd
£58.5k - Industry AVG
Efficiency
resulting in sales per employee of £46.1k, this is less efficient (£225.4k)
£46.1k - Renishaw Neuro Solutions Ltd
£225.4k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is near the average (52 days)
50 days - Renishaw Neuro Solutions Ltd
52 days - Industry AVG
Creditor Days
its suppliers are paid after 42 days, this is slower than average (27 days)
42 days - Renishaw Neuro Solutions Ltd
27 days - Industry AVG
Stock Days
it holds stock equivalent to 280 days, this is more than average (98 days)
280 days - Renishaw Neuro Solutions Ltd
98 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 10 weeks, this is less cash available to meet short term requirements (28 weeks)
10 weeks - Renishaw Neuro Solutions Ltd
28 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 232.7%, this is a higher level of debt than the average (48.7%)
232.7% - Renishaw Neuro Solutions Ltd
48.7% - Industry AVG
RENISHAW NEURO SOLUTIONS LTD financials
EXPORT
Renishaw Neuro Solutions Ltd's latest turnover from June 2023 is £2.2 million and the company has net assets of -£10.7 million. According to their latest financial statements, Renishaw Neuro Solutions Ltd has 47 employees and maintains cash reserves of £180.3 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Turnover
2,167,881
2,537,879
4,101,028
172,832
Other Income Or Grants
Cost Of Sales
942,766
1,287,955
737,245
28,224
Gross Profit
1,225,115
1,249,924
3,363,783
144,608
Admin Expenses
7,390,645
4,736,780
5,005,632
1,080,929
Operating Profit
-6,165,530
-3,486,856
-1,641,849
-936,321
Interest Payable
670,593
222,776
112,608
16,957
Interest Receivable
21,185
Pre-Tax Profit
-6,814,938
-3,709,632
-1,754,457
-953,278
Tax
1,443,460
654,285
227,278
180,474
Profit After Tax
-5,371,478
-3,055,347
-1,527,179
-772,804
Dividends Paid
Retained Profit
-5,371,478
-3,055,347
-1,527,179
-772,804
Employee Costs
3,111,725
2,688,834
2,452,246
559,727
Number Of Employees
47
40
37
41
EBITDA*
-5,674,159
-2,982,636
-823,613
-777,583
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Tangible Assets
223,004
3,104,916
318,947
415,990
Intangible Assets
2,237,256
4,252,152
4,359,880
4,864,005
Investments & Other
1,301,709
2,817,054
Debtors (Due After 1 year)
1,622,427
Total Fixed Assets
5,384,396
7,357,068
4,678,827
5,279,995
Stock & work in progress
723,970
817,484
965,806
604,979
Trade Debtors
300,801
113,210
1,168,788
180,851
Group Debtors
13,642
17,570
Misc Debtors
1,496,252
1,198,818
587,364
21,378
Cash
180,300
167,355
798,918
406,720
misc current assets
total current assets
2,701,323
2,296,867
3,534,518
1,231,498
total assets
8,085,719
9,653,935
8,213,345
6,511,493
Bank overdraft
Bank loan
Trade Creditors
110,876
45,056
148,263
5,040
Group/Directors Accounts
130,452
other short term finances
hp & lease commitments
other current liabilities
625,161
1,030,298
900,561
1,049,478
total current liabilities
866,489
1,075,354
1,048,824
1,054,518
loans
17,626,522
hp & lease commitments
Accruals and Deferred Income
other liabilities
13,254,717
8,891,182
5,801,062
provisions
319,515
1,358,386
1,146,642
857,432
total long term liabilities
17,946,037
13,933,910
9,464,503
6,229,778
total liabilities
18,812,526
15,009,264
10,513,327
7,284,296
net assets
-10,726,807
-5,355,329
-2,299,982
-772,803
total shareholders funds
-10,726,807
-5,355,329
-2,299,982
-772,803
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Operating Activities
Operating Profit
-6,165,530
-3,486,856
-1,641,849
-936,321
Depreciation
87,475
92,160
98,472
27,738
Amortisation
403,896
412,060
719,764
131,000
Tax
1,443,460
654,285
227,278
180,474
Stock
-93,514
-148,322
360,827
604,979
Debtors
2,107,452
-457,766
1,549,995
219,799
Creditors
65,820
-103,207
143,223
5,040
Accruals and Deferred Income
-405,137
129,737
-148,917
1,049,478
Deferred Taxes & Provisions
-1,038,871
211,744
289,210
857,432
Cash flow from operations
-7,622,825
-1,483,989
-2,223,641
490,063
Investing Activities
capital expenditure
4,405,437
-3,182,461
-217,068
-5,438,733
Change in Investments
-1,515,345
2,817,054
cash flow from investments
5,920,782
-5,999,515
-217,068
-5,438,733
Financing Activities
Bank loans
Group/Directors Accounts
130,452
Other Short Term Loans
Long term loans
17,626,522
Hire Purchase and Lease Commitments
other long term liabilities
-13,254,717
4,363,535
3,090,120
5,801,062
share issue
1
interest
-649,408
-222,776
-112,608
-16,957
cash flow from financing
3,852,849
4,140,759
2,977,512
5,784,106
cash and cash equivalents
cash
12,945
-631,563
392,198
406,720
overdraft
change in cash
12,945
-631,563
392,198
406,720
renishaw neuro solutions ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for renishaw neuro solutions ltd. Get real-time insights into renishaw neuro solutions ltd's credit score, group structure and payment trends.
Perform a competitor analysis for renishaw neuro solutions ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in GL12 area or any other competitors across 12 key performance metrics.
renishaw neuro solutions ltd Ownership
RENISHAW NEURO SOLUTIONS LTD group structure
Renishaw Neuro Solutions Ltd has no subsidiary companies.
The sole shareholder of Renishaw Neuro Solutions Ltd is Renishaw Medical Limited.
renishaw medical limited
100%
renishaw neuro solutions ltd directors
Renishaw Neuro Solutions Ltd currently has 3 directors.
The longest serving directors include
Mr Allen Roberts (Dec 2016) and
Mr Rupert Jones (Aug 2017).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to renishaw neuro solutions ltd.
renishaw neuro solutions ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RENISHAW NEURO SOLUTIONS LTD. This can take several minutes, an email will notify you when this has completed.
renishaw neuro solutions ltdCompanies House Filings - See Documents
